Cassava Sciences Inc (SAVA)
25.95
-0.26
(-0.99%)
USD |
NASDAQ |
Nov 04, 13:14
Cassava Sciences Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2013 | 93.68% |
| September 30, 2013 | -38.92% |
| June 30, 2013 | -15.36% |
| March 31, 2013 | -20.84% |
| December 31, 2012 | -72.69% |
| September 30, 2012 | -56.88% |
| June 30, 2012 | -4.77% |
| March 31, 2012 | 1.01% |
| December 31, 2011 | -14.23% |
| September 30, 2011 | -29.65% |
| June 30, 2011 | -43.60% |
| March 31, 2011 | -6.40% |
| December 31, 2010 | -114.5% |
| September 30, 2010 | -35.51% |
| June 30, 2010 | -30.27% |
| March 31, 2010 | -31.39% |
| December 31, 2009 | -7.96% |
| September 30, 2009 | -34.87% |
| June 30, 2009 | -0.55% |
| March 31, 2009 | -26.69% |
| December 31, 2008 | -16.85% |
| September 30, 2008 | 50.15% |
| June 30, 2008 | -9.72% |
| March 31, 2008 | 17.56% |
| December 31, 2007 | 8.05% |
| Date | Value |
|---|---|
| September 30, 2007 | 20.07% |
| June 30, 2007 | 23.92% |
| March 31, 2007 | 57.30% |
| December 31, 2006 | -90.14% |
| September 30, 2006 | 52.17% |
| June 30, 2006 | 9.94% |
| March 31, 2006 | 5.72% |
| December 31, 2005 | |
| September 30, 2005 | |
| June 30, 2005 | |
| March 31, 2005 | |
| December 31, 2004 | |
| September 30, 2004 | |
| June 30, 2004 | |
| March 31, 2004 | |
| December 31, 2003 | |
| September 30, 2003 | |
| June 30, 2003 | |
| March 31, 2003 | |
| December 31, 2002 | |
| September 30, 2002 | |
| June 30, 2002 | |
| March 31, 2002 | |
| December 31, 2001 | |
| September 30, 2001 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 10.18% |
| Eli Lilly and Co | 8.48% |
| Seelos Therapeutics Inc | -- |
| Biomarin Pharmaceutical Inc | 14.22% |
| EyePoint Pharmaceuticals Inc | -325.3% |